Featured Research

from universities, journals, and other organizations

Reliable culture of human embryonic stem cells

Date:
November 27, 2010
Source:
The Biochemical Society
Summary:
Human embryonic stem cells have enormous potential for use in pharmaceutical development and therapeutics; however, to realize this potential there is a requirement for simple and reproducible cell culture methods that provide adequate numbers of cells of suitable quality.

Human embryonic stem cells have enormous potential for use in pharmaceutical development and therapeutics; however, to realize this potential there is a requirement for simple and reproducible cell culture methods that provide adequate numbers of cells of suitable quality.

Related Articles


A team of researchers at the University of Glasgow and Heriot-Watt University, Edinburgh, have discovered a new way of blocking the spontaneous differentiation of stem cells by using the compound erythro-9-(2-hydroxy-3-nonyl)adenine (EHNA). As explained by Peter Burton and colleagues in their paper published in the ChemBio Knowledge Environment of the Biochemical Journal, this means that human embryonic stem cells can be maintained in an undifferentiated state whilst remaining capable of differentiating to all cell types in the body, thus realizing their huge potential as research tools and for cell therapies.

Importantly, the EHNA treatment did not 'lock' the stem cells in an undifferentiated state, as the EHNA was removed, the cells were capable of multi-lineage differentiation.

The researchers note that EHNA is a robust, stable compound, readily prepared from commercially available starting materials at low cost in just two synthetic steps.

Bart Vanhaesebroeck, Deputy Chair for the BJ ChemBio Knowledge Environment, said: said "These findings have immense potential implications for bringing stem cell therapies closer to the clinic."


Story Source:

The above story is based on materials provided by The Biochemical Society. Note: Materials may be edited for content and length.


Journal Reference:

  1. Peter Burton, David Adams, Achamma Abraham, Robert Allcock, Zhong Jiang, Angela McCahill, Jane Gilmour, John McAbney, Alexander Kaupisch, Nicole Kane, George Baillie, Andrew Baker, Graeme Milligan, Miles Houslay, Joanne Mountford. Erythro-9-(2-hydroxy-3-nonyl)adenine (EHNA) blocks differentiation and maintains the expression of pluripotency markers in human embryonic stem cells. Biochemical Journal, 2010; DOI: 10.1042/BJ20100726

Cite This Page:

The Biochemical Society. "Reliable culture of human embryonic stem cells." ScienceDaily. ScienceDaily, 27 November 2010. <www.sciencedaily.com/releases/2010/11/101126094456.htm>.
The Biochemical Society. (2010, November 27). Reliable culture of human embryonic stem cells. ScienceDaily. Retrieved November 27, 2014 from www.sciencedaily.com/releases/2010/11/101126094456.htm
The Biochemical Society. "Reliable culture of human embryonic stem cells." ScienceDaily. www.sciencedaily.com/releases/2010/11/101126094456.htm (accessed November 27, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Thursday, November 27, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Ebola Leaves Orphans Alone in Sierra Leone

Ebola Leaves Orphans Alone in Sierra Leone

AFP (Nov. 27, 2014) — The Ebola epidemic sweeping Sierra Leone is having a profound effect on the country's children, many of whom have been left without any family members to support them. Duration: 01:02 Video provided by AFP
Powered by NewsLook.com
Experimental Ebola Vaccine Shows Promise In Human Trial

Experimental Ebola Vaccine Shows Promise In Human Trial

Newsy (Nov. 27, 2014) — A recent test of a prototype Ebola vaccine generated an immune response to the disease in subjects. Video provided by Newsy
Powered by NewsLook.com
Pet Dogs to Be Used in Anti-Ageing Trial

Pet Dogs to Be Used in Anti-Ageing Trial

Reuters - Innovations Video Online (Nov. 26, 2014) — Researchers in the United States are preparing to discover whether a drug commonly used in human organ transplants can extend the lifespan and health quality of pet dogs. Video provided by Reuters
Powered by NewsLook.com
Today's Prostheses Are More Capable Than Ever

Today's Prostheses Are More Capable Than Ever

Newsy (Nov. 26, 2014) — Advances in prosthetics are making replacement body parts stronger and more lifelike than they’ve ever been. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins